Brief summary

This study will examine outcomes for patients treated by planned culotte stenting and compare outcomes with 2 different stent platforms, the next generation Synergy II and the Xience Xpedition DES platforms.

Primary endpoints

• Composite measure of Adverse events [ Time Frame: 9 months ]

Composite of: Death, Myocardial Infarction, CVA, Target Vessel Failure (Composite of Target Vessel Revascularization and Target Vessel Inadequacy), Definite or Probable stent thrombosis (ARC criteria [14]), Binary angiographic restenosis

CERC Services

Full services – CERIC Sponsor:

• Submission,
• Monitoring,
• Statistics,
• Final report,
• CEC.

Countries

UK & Ireland managed by CERC.

Centers number

9 centers managed by CERC.